Massive heart study hopes troponin test outperforms old risk tools
NCT ID NCT04903041
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to see if a high-sensitivity troponin blood test can better sort people into low, moderate, or high risk for heart disease compared to standard checks. Researchers will enroll up to 300,000 adults in India who are already getting routine health screenings. The goal is to improve early detection and guide lifestyle or treatment recommendations to reduce heart attacks and strokes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Apollo Hospitals
Bangalore, India
-
Apollo Hospitals
Chennai, India
-
Apollo Hospitals
Hyderabad, India
-
Apollo Hospitals
Kolkata, India
-
Apollo Hospitals
Mumbai, India
-
Apollo Hospitals
New Delhi, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can better healthcare access save hearts after prison?
- Can lifestyle choices after a stroke extend life and prevent a second one?
- Could a simple health chat slash heart disease and cancer risk?
- One scan, many answers: can a new CT predict heart risks after stenting?
- Digital coaching aims to boost heart health in obesity
- Can a new device suck out deadly lung clots?